FOLH1 and prostate cancer: Increased expression of PSMA from benign prostatic hyperplasia to high grade intraepithelial neoplasia and to adenocarcinomas [2] as well as overexpression in all stages and grades of prostate cancer (PC) suggest that PSMA plays a pivotal cancer-driving role [3].